21 articles for RK Hom
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
28
Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: prime side chromane-containing inhibitors.

Elan Pharmaceuticals
30
Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors.

Elan Pharmaceuticals
2
Design and synthesis of thiophene dihydroisoquinolines as novel BACE1 inhibitors.

Elan Pharmaceuticals
17
Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates.

Elan Pharmaceuticals
42
Improving the permeability of the hydroxyethylamine BACE-1 inhibitors: structure-activity relationship of P2' substituents.

Elan Pharmaceuticals
41
Design and synthesis of cell potent BACE-1 inhibitors: structure-activity relationship of P1' substituents.

Elan Pharmaceuticals
42
Design of substrate-based inhibitors of human beta-secretase.

TBA
29
Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration.

Elan Pharmaceuticals
33
Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor.

Elan Pharmaceuticals
32
Highly selective c-Jun N-terminal kinase (JNK) 2 and 3 inhibitors with in vitro CNS-like pharmacokinetic properties prevent neurodegeneration.

Elan Pharmaceuticals
57
Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK.

Elan Pharmaceuticals
19
Design of an orally efficacious hydroxyethylamine (HEA) BACE-1 inhibitor in a preclinical animal model.

Elan Pharmaceuticals
44
Design and synthesis of hydroxyethylamine (HEA) BACE-1 inhibitors: structure-activity relationship of the aryl region.

Elan Pharmaceuticals
38
Design and synthesis of statine-based cell-permeable peptidomimetic inhibitors of human beta-secretase.

Elan Pharmaceuticals
29
N-Bridged bicyclic sulfonamides as inhibitors of gamma-secretase.

Elan Pharmaceuticals
48
Design, synthesis, and structure-activity relationship of novel orally efficacious pyrazole/sulfonamide based dihydroquinoline gamma-secretase inhibitors.

Elan Pharmaceuticals
7
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors

Abbvie Deutschland
4
Lactosamine-Based Derivatives as Tools to Delineate the Biological Functions of Galectins: Application to Skin Tissue Repair.

Universit�� De Nantes
563
Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors

Merck Sharp & Dohme
20
Inhibitors of the Diadenosine Tetraphosphate Phosphorylase Rv2613c of Mycobacterium tuberculosis.

University of Konstanz
8
Synthesis and biological activity of N-aryl-2-aminothiazoles: potent pan inhibitors of cyclin-dependent kinases.

Bristol Myers Squibb